跳至主要内容
临床试验/NCT01900795
NCT01900795终止2 期

A Phase 2a, Single-Center, Randomized, Double-Blind, Double- Dummy, Placebo- and Active-Controlled Analgesic Study of an Oral Dose of V117957 4.5 mg for the Treatment of Postsurgical Pain Due to Third Molar Extraction

Purdue Pharma LP1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2013年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
114
试验地点
1
主要终点
Total pain relief 0 to 8 hours after dosing (TOTPAR8)

研究概览

简要总结

The primary objective of this study is to assess the analgesic properties of an oral dose of V117957 4.5 mg aqueous suspension in the third molar extraction model

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

V117957

Experimental

干预措施: V117957 (Drug)

Ibuprofen

Active Comparator

干预措施: Ibuprofen (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Total pain relief 0 to 8 hours after dosing (TOTPAR8)

时间窗: 0 - 8 hours postdose

Time-weighted sum of pain relief scores 0 to 8 hours after dosing

次要结局

  • Time to meaningful PR(Up to 24 hours postdose)
  • Time to first use of rescue pain medication(Up to 24 hours postdose)
  • Proportion of subjects taking rescue medication by time point(Up to 24 hours postdose)
  • Global assessment of overall satisfaction(Hour 24 postdose)
  • Total Pain Relief 0 - 4 hours after dosing (TOTPAR4)(Hour 4 postdose)
  • Total Pain Relief 0 - 6 hours after dosing (TOTPAR6)(Hour 6 postdose)
  • Total Pain Relief 0 - 12 hours after dosing (TOTPAR12)(Hour 12 postdose)
  • Total Pain Relief 0 - 24 hours after dosing (TOTPAR24)(Hour 24 postdose)
  • Pain Relief (PR) over time(Up to 24 hours postdose)
  • Pain intensity difference over time(15, 30, 45 , 60, 90 minutes; 2, 3, 4, 4.5, 6, 8, 10, 12 and 24 hours postdose)
  • Sum of pain intensity difference 0 to 4 hours after dosing (SPID4)(Hour 4 postdose)
  • Sum of pain intensity difference 0 to 6 hours after dosing (SPID6)(Hour 6 postdose)
  • Sum of pain intensity difference 0 to 8 hours after dosing (SPID8)(Hour 8 postdose)
  • Sum of pain intensity difference 0 to 12 hours after dosing (SPID12)(Hour 12 postdose)
  • Sum of pain intensity difference 0 to 24 hours after dosing (SPID24)(Hour 24 postdose)
  • Time to first perceptible PR(Up to 24 hours postdose)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验